-
Company Insights
Innovation and Patenting activity of ACI Worldwide Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of ACI Worldwide Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACI-7104 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACI-7104 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ACI-7104 in Parkinson's Disease Drug Details:PD-01 (PD-01A) is under development for the treatment...
-
Thematic Analysis
NewWeb3 – Thematic Intelligence
Web3 Thematic Report Overview Web3 is an ideology that refers to the next model of the internet built on blockchain. It promises a mix of peer-to-peer (P2P) communication channels and decentralized governance. This will lead the internet’s transition from an information-centric model to a user-centric model. Furthermore, Web3 aims to give users the ability to create, own, and monetize their content and manage the use of their data. However, it is still an emerging model and has a long way...
-
Thematic Analysis
Payments Sector Scorecard – Thematic Intelligence
Payments Sector Scorecard Thematic Intelligence Report Overview Disruptive solutions such as blockchain, AI, and cloud technology are driving changes in the payments industry. Companies such as JPMorgan Chase, GoogleC, Visa, and Mastercard are heavily investing in these solutions even though they are at their early stage of using disruptive technologies. In addition, incumbent companies acquire startups and stakes in competitors to grow their market share. Fintech startups first showed interest in new payment solutions such as open banking, blockchain, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KITE-222 in Refractory Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KITE-222 in Refractory Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KITE-222 in Refractory Chronic Lymphocytic Leukemia (CLL) Drug...
-
Thematic Analysis
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...
-
Analyst Opinions
Key Payments Trends for 2024
Exploring trends and insights from the ‘Payments Trends’ report will help you: Identify the top trends impacting the payment industry - mobile payments, social commerce, alternative solutions, AI, open banking, and blockchain. Analyze the leading trends in the industry and learn how they provide fast and frictionless user experiences. Understand each trend in detail to gain a competitive advantage in the market. Identify factors driving the growth of the payments landscape, including super apps, mobile payments, and blockchain. Understand the...
-
Product Insights
Colmac Biomass Power Plant
Colmac Biomass Power Plant is a biopower project located in California, United States. The project is owned by Greenleaf Power LLC and was developed by ACI Energy Inc. The project came online in 1992. Empower your strategies with our Colmac Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Pecineaga Wind Farm
Pecineaga Wind Farm is an Onshore Wind project located in Constanta, Romania. The project is owned by Eurowind Energy AS and is developed by ACI (Pvt) Ltd; Eurowind Energy AS. The project is currently under construction. Empower your strategies with our Pecineaga Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Citarinostat in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Citarinostat in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Citarinostat in Relapsed Multiple Myeloma Drug Details: Citarinostat (ACY-241) is under...